Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Repros Therapeutics Inc."
Count: 59
Selected: 0
NCT IDTitle
NCT01728454Safety and Efficacy of Telapristone Acetate (Proellex®) in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
NCT02811159An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids
NCT02651688A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene
NCT02323646Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids
NCT00620503Proellex® Pharmacokinetic Bridging Study II
NCT02301897A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids
NCT00958334Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003
NCT01984398Comparison of Two Formulations of Androxal
NCT00749879Crossover Study of the Safety and PK Properties of Proellex®
NCT00958412Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study
NCT01386606The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)
NCT00706719To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone
NCT01739595Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism
NCT01532414Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism
NCT02274181An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration
NCT02169804An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal
NCT01993225A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%
NCT01993212A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%
NCT01619683Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
NCT02141061Comparison of Two Formulations of Proellex for Oral Administration
NCT01451424Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids
NCT00741273Evaluate the Safety and PK of Proellex® in Female Patients With Impaired Hepatic Function and Healthy Adults
NCT00958893An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext
NCT00881608Study to Evaluate Menses Induction in Women Administered Proellex
NCT00787618Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females
NCT00556075Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis
NCT00741468Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects
NCT01069120Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids
NCT00853567Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids
NCT00785356Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids
NCT00737282Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids
NCT00735553Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids
NCT00702702Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids
NCT00683917Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
NCT02146391Study to Evaluate the Effect of Food Upon the Pharmacokinetics of Androxal
NCT01991327Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy Males
NCT01959685A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of Androxal
NCT01923857Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal Function
NCT00619385A Safety and Pharmacokinetic Study of Proellex®
NCT01270841Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism
NCT01187043Determination of the Lowest, Safe and Effective Dose of Proellex
NCT01534208Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
NCT01191320Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus
NCT01067807Proellex Pharmacokinetics Bridging Study
NCT00882258Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
NCT00881062Investigate Absorption, Metabolism and Excretion of [14C}-Proellex Following Single Oral Dose in Healthy Females
NCT01069094A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
NCT01067365Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism
NCT00874302Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms
NCT02117830A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects